Latest Articles

Publication Date
New treatment for endometriosis now available in NZ - Otago Daily Times

New treatment for endometriosis now available in NZ Otago Daily Times

Published: Oct. 9, 2025, 1 a.m.
Progestagens for pain symptoms associated with endometriosis.

Endometriosis is a hormone-sensitive inflammatory condition affecting between 5% and 10% of reproductive-aged women and an unknown number of gender-diverse individuals. It is often associated with debilitating pelvic pain symptoms. …

Published: Oct. 9, 2025, midnight
Letter to the editor: Autoimmunity in endometriosis: time to reframe our diagnostic and treatment approach.

Published: Oct. 9, 2025, midnight
New treatment for endometriosis now available in New Zealand - RNZ

New treatment for endometriosis now available in New Zealand RNZ

Published: Oct. 8, 2025, 8:23 p.m.
New treatment for endometriosis is now available in NZ - RNZ

New treatment for endometriosis is now available in NZ RNZ

Published: Oct. 8, 2025, 7:56 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider

Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Oct. 8, 2025, 7:30 p.m.
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com

Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com

Published: Oct. 8, 2025, 2:15 p.m.
Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment - The Malaysian Reserve

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment The Malaysian Reserve

Published: Oct. 8, 2025, 10:56 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post

Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve

Published: Oct. 8, 2025, 2:14 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!